AGP Picks
View all

Tech Times of New York
Provided by AGP

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on September 14, 2026

Host Hotels & Resorts Announces Third Quarter 2026 Earnings Call to be Held on November 5, 2026
Sep. 14, 2026

Host Hotels & Resorts Announces Third Quarter 2026 Earnings Call to be Held on November 5, 2026

Indeterminate GlobeNewswire
The Children’s Place Reports Second Quarter 2026 Results
Sep. 14, 2026

The Children’s Place Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire
WIX DEADLINE: Wix.com Ltd. Investors Should Contact Block & Leviton About Pending Lawsuit Before September 22, 2026
Sep. 14, 2026

WIX DEADLINE: Wix.com Ltd. Investors Should Contact Block & Leviton About Pending Lawsuit Before September 22, 2026

Indeterminate GlobeNewswire
Ocean Power Technologies Announces First Quarter Fiscal 2027 Results
Sep. 14, 2026

Ocean Power Technologies Announces First Quarter Fiscal 2027 Results

Indeterminate GlobeNewswire
Yatra Issues Statement in Response to Magna’s Amendment and Extension of Its Unsolicited Tender Offer
Sep. 14, 2026

Yatra Issues Statement in Response to Magna’s Amendment and Extension of Its Unsolicited Tender Offer

Indeterminate GlobeNewswire
Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study
Sep. 14, 2026

Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study

Indeterminate GlobeNewswire
Globus Maritime Limited Announces the Delivery of a 2026-Built Ultramax Dry Bulk Vessel “Glbs Olympia,” Expanding Fleet to Ten Vessels
Sep. 14, 2026

Globus Maritime Limited Announces the Delivery of a 2026-Built Ultramax Dry Bulk Vessel “Glbs Olympia,” Expanding Fleet to Ten Vessels

Indeterminate GlobeNewswire
American Coastal Insurance Corporation Announces Restructured Exclusive Managing Agency Agreement with AmRisc, LLC
Sep. 14, 2026

American Coastal Insurance Corporation Announces Restructured Exclusive Managing Agency Agreement with AmRisc, LLC

Indeterminate GlobeNewswire
PetMeds Appoints Andrew Parry as Chief Technology Officer
Sep. 14, 2026

PetMeds Appoints Andrew Parry as Chief Technology Officer

Indeterminate GlobeNewswire
Dave & Buster’s Reports Second Quarter 2026 Financial Results
Sep. 14, 2026

Dave & Buster’s Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer
Sep. 14, 2026

Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer

Indeterminate GlobeNewswire
Asia Pacific Wire & Cable Corporation Limited Announces Results of 2026 Annual General Meeting and Corporate Updates
Sep. 14, 2026

Asia Pacific Wire & Cable Corporation Limited Announces Results of 2026 Annual General Meeting and Corporate Updates

Indeterminate GlobeNewswire
NurExone and NanoPass Technologies Ltd. to Collaborate on Integrated Exosome Delivery Approach for Regenerative Eye and Skin Applications
Sep. 14, 2026

NurExone and NanoPass Technologies Ltd. to Collaborate on Integrated Exosome Delivery Approach for Regenerative Eye and Skin Applications

Indeterminate GlobeNewswire
Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial
Sep. 14, 2026

Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial

Indeterminate GlobeNewswire
Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings
Sep. 14, 2026

Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings

Indeterminate GlobeNewswire
Priority Income Fund Announces Preferred Stock Distributions for September 2026
Sep. 14, 2026

Priority Income Fund Announces Preferred Stock Distributions for September 2026

Indeterminate GlobeNewswire
Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results
Sep. 14, 2026

Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results

Indeterminate GlobeNewswire
Priority Income Fund Announces Redemption of its 6.375% Series L Term Preferred Stock Due 2029
Sep. 14, 2026

Priority Income Fund Announces Redemption of its 6.375% Series L Term Preferred Stock Due 2029

Indeterminate GlobeNewswire
BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid
Sep. 14, 2026

BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid

Indeterminate GlobeNewswire
Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update
Sep. 14, 2026

Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Times of New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.